TC Build Mode

Startup Battlefield Credibility Simulator

Credibility Signal Drivers

Model investor perception across deep tech defensibility vectors.

Nephrogen Case Study
75
Domain expertise, prior venture exits, MIT/Stanford/Harvard deep tech pedigree.
85
Issued composition-of-matter patents, exclusive university tech transfer licenses.
90
Nature/Science publications, reproducible pre-clinical animal models, blind benchmarks.
80
Paid enterprise/pharma feasibility studies, LOIs with milestones, lab evaluations.
70
Pre-IND FDA guidance meetings, clear 510(k) or De Novo path, clinical endpoints mapped.

Demetri Mxm's Battlefield Credibility Tactics

Toggle specific pitch narrative structures recommended in Build Mode:

Investor Perception Metrics

Real-time risk mitigation and VC funding probability

Algorithm v2.4 Active
Investor Confidence Score
82 / 100
High Conviction
Investor Risk Score
18 / 100
Optimized for Deep Tech VC
Pitch Delivery Recommendation

Reinforce regulatory milestone timeline and intellectual property moat.

Real-time Investor Risk Breakdown

Distribution of perceived risk across pitch evaluation categories:

Credibility Factor Evaluation Weight Score Weighted Contribution
Export Startup Pitch Credibility Scorecard

Save formatted diligence summary for your pitch deck appendix or investor Q&A prep.

Context & Evidence: Methodology derived from TechCrunch's Build Mode breakdown by Eike Gerhardt analyzing Demetri Mxm's Startup Battlefield presentation of Nephrogen (Synthetic Biology & Deep Tech). Designed to transform pre-revenue clinical/scientific ambiguity into verifiable investor conviction signals.